Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.04
+0.09 (0.43%)
At close: Mar 6, 2026, 4:00 PM EST
21.05
+0.01 (0.05%)
After-hours: Mar 6, 2026, 7:51 PM EST
Immunome Stock Forecast
Stock Price Forecast
The 10 analysts that cover Immunome stock have a consensus rating of "Strong Buy" and an average price target of $32.8, which forecasts a 55.89% increase in the stock price over the next year. The lowest target is $22 and the highest is $40.
Price Target: $32.8 (+55.89%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunome stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 6 | 6 |
| Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $33 → $36 | Strong Buy | Maintains | $33 → $36 | +71.10% | Mar 4, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $33 → $30 | Buy | Maintains | $33 → $30 | +42.59% | Mar 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +90.11% | Feb 12, 2026 |
| Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +47.34% | Jan 15, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $22 → $32 | Strong Buy | Maintains | $22 → $32 | +52.09% | Dec 16, 2025 |
Financial Forecast
Revenue This Year
8.22M
from 6.94M
Increased by 18.41%
Revenue Next Year
79.17M
from 8.22M
Increased by 863.23%
EPS This Year
-2.69
from -2.43
EPS Next Year
-2.30
from -2.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 27.9M | 227.2M | |||
| Avg | 8.2M | 79.2M | |||
| Low | n/a | 6.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 302.4% | 2,664.3% | |||
| Avg | 18.4% | 863.2% | |||
| Low | - | -16.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.02 | -1.60 | |||
| Avg | -2.69 | -2.30 | |||
| Low | -3.45 | -3.49 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.